Effective as of April 15, 2022 (the Separation Date), Samuel Barone, M.D. will depart as the Chief Medical Officer of Gemini Therapeutics, Inc.
Effective as of April 15, 2022 (the Separation Date), Samuel Barone, M.D. will depart as the Chief Medical Officer of Gemini Therapeutics, Inc.